Buprenorphine Maintenance for Opioid Addicts - 2 - Full Text View

Buprenorphine Maintenance for Opioid Addicts - 2

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) Yale University
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000203

Purpose

The purpose of this study is to evaluate varying doses of buprenorphine for opioid dependence and cocaine abuse.

Condition	Intervention	Phase
Opioid-Related Disorders	Drug: Buprenorphine	Phase II

ChemIDplus related topics:

Buprenorphine Buprenorphine hydrochloride

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	Buprenorphine Maintenance for Opioid Addicts

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Estimated Enrollment:

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000203

Locations


United States, Connecticut
	VA Connecticut Healthcare System
	New Haven, Connecticut, United States, 06519

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Yale University

Investigators


Principal Investigator:	Thomas R Kosten, M.D.	VA Connecticut Healthcare System

More Information

Study ID Numbers:	NIDA-05626-2, R01-05626-2
First Received:	September 20, 1999
Last Updated:	August 23, 2005
ClinicalTrials.gov Identifier:	NCT00000203
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Buprenorphine

Mental Disorders

Substance-Related Disorders

Disorders of Environmental Origin

Opioid-Related Disorders

Additional relevant MeSH terms:

Sensory System Agents

Therapeutic Uses

Narcotic Antagonists

Physiological Effects of Drugs

Central Nervous System Depressants

Narcotics

Peripheral Nervous System Agents

Analgesics

Central Nervous System Agents

Pharmacologic Actions

Analgesics, Opioid

ClinicalTrials.gov processed this record on September 05, 2008